激活Pgk1导致在各种神经退行性疾病中减少蛋白质聚合
Hao Chen1, Yajie Li1, Jingwen Gao1
1Department of Biochemistry and Molecular Biology School of Basic Medicine, Capital Medical University, Youanmen, Beijing, 100069, China.
Molecular neurobiology
|May 30, 2023
概括
现在 (TZ) 通过激活糖酸酶1 (Pgk1) 和Hsp90.0. 通过激活神经退行性疾病模型中预防病态蛋白质凝聚物. 这种候选药物增加了ATP水平并促进了自,提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 蛋白质凝结物与神经退行性疾病有关.
- 现在素 (TZ) 是α1上腺素受体对手,激活糖酸酶1 (Pgk1) 和Hsp90.0.
- 之前的工作确定了TZ与Pgk1和Hsp90.0的相互作用.
研究的目的:
- 调查TZ在预防各种病理性蛋白质凝结物形成方面的有效性.
- 阐明TZ作用背后的分子机制.
主要方法:
- 用TZ处理的初级神经元培养物.
- 细胞测定用于化在肉瘤 (FUS) -P525L-GFP.
- 使用Drosophila,APP/PS1阿尔茨海默病小鼠模型和α-synuclein大鼠模型的体内研究.
主要成果:
- TZ减少了神经元中的FUS-P525L-GFP密度和丰度.
- 细胞内ATP水平的增加对于总量减少至关重要.
- TZ增强了Hsp90与ULK1的相互作用,ULK1是一个关键的自调节器.
- 在体内,TZ可以预防和逆转病态蛋白质凝结物.
结论:
- 通过向蛋白质凝聚物,TZ显示了治疗神经退行性疾病的潜力.
- 通过TZ激活Pgk1,可以通过增加ATP溶解聚合物,并通过自促进降解.
- 需要进一步的研究来澄清核FUS-P525L降解途径.
关键词:
AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD ADD was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was这就是ATPATPATP ATP.自自是一种自的过程.这就是FUS FUS.葡萄糖溶解是什么? 葡萄糖溶解神经退行性疾病是一种神经退行性疾病.警方 警方 警方 警方一个PGK1一个PGK1塔乌·塔乌 (Tau Tau) 是一个现在,他已经接受了治疗.α-Synuclein 是一种蛋白质.更多相关视频
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
7.6K
06:14Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue
Published on: May 8, 2018
8.8K
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
The Proteasome
915
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
915
